NASDAQ:SLNO 30 December 2025 - 7 April 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Soleno Therapeutics Pulls Europe Drug Filing After $2.9 Billion Neurocrine Deal

Soleno Therapeutics yanked its European application for VIOKAT on Tuesday, just a day after striking a $2.9 billion cash deal to be acquired by Neurocrine Biosciences. That move halts a regulatory review Soleno had earlier projected might wrap up by mid-2026.

7 April 2026

Biotechnology·NASDAQ:NBIX·NASDAQ:SLNO·Pharmaceuticals

Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Neurocrine Biosciences is set to buy Soleno Therapeutics Inc. in a $2.9 billion all-cash transaction announced Monday, offering $53 per share to Soleno holders. Shares of the rare-disease specialist traded at $52.25, just shy of the bid.

7 April 2026

NASDAQ:NBIX·NASDAQ:SLNO·Pharmaceuticals·Stock Market

Soleno Therapeutics stock jumps nearly 9% today — what SLNO traders are watching next

Soleno Therapeutics, Inc. shares surged 8.9% to close at $42.00 on Monday, hitting a peak of $42.03 and dipping to $38.57 during Nasdaq’s regular session.

2 February 2026

NASDAQ:SLNO·Stock Market

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Soleno Therapeutics shares slid on Friday, extending a choppy stretch for the rare-disease drugmaker. The stock was down 5.6% at $42.95, after touching a low of $42.73, while the SPDR S&P Biotech ETF was up about 1.1%.

9 January 2026

NASDAQ:SLNO·Pharmaceutical News·Stock Market

Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips

Shares of Soleno Therapeutics, Inc. fell 3.1% to $46.09 in afternoon trading on Tuesday, after a law firm said it was investigating potential claims on behalf of investors. The drop outpaced declines in biotech benchmarks, with the SPDR S&P Biotech ETF down about 1.4% and the iShares Nasdaq Biotechnology ETF off about 1.1%.

30 December 2025

NASDAQ:SLNO

Go toTop